O
30.28
-0.67 (-2.16%)
| Penutupan Terdahulu | 30.95 |
| Buka | 30.76 |
| Jumlah Dagangan | 687,409 |
| Purata Dagangan (3B) | 554,990 |
| Modal Pasaran | 1,418,424,192 |
| Harga / Pendapatan (P/E TTM) | 112.15 |
| Harga / Jualan (P/S) | 1.31 |
| Harga / Buku (P/B) | 1.18 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 May 2025 |
| Margin Keuntungan | 1.13% |
| Margin Operasi (TTM) | 4.49% |
| EPS Cair (TTM) | 0.270 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 18.60% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 55.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 30.77% |
| Nisbah Semasa (MRQ) | 1.37 |
| Aliran Tunai Operasi (OCF TTM) | 187.72 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 146.87 M |
| Pulangan Atas Aset (ROA TTM) | 0.16% |
| Pulangan Atas Ekuiti (ROE TTM) | 1.03% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Health Information Services (US) | Menurun | Bercampur |
| Health Information Services (Global) | Menurun | Bercampur | |
| Stok | Omnicell, Inc. | Menurun | Menurun |
AISkor Stockmoo
0.0
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -4.0 |
| Purata | 0.00 |
|
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States. |
|
| Sektor | Healthcare |
| Industri | Health Information Services |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 1.69% |
| % Dimiliki oleh Institusi | 101.10% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 40.00 (Benchmark, 32.10%) | Beli |
| Median | 36.00 (18.89%) | |
| Rendah | 31.00 (Wells Fargo, 2.38%) | Pegang |
| Purata | 35.67 (17.80%) | |
| Jumlah | 1 Beli, 2 Pegang | |
| Harga Purata @ Panggilan | 32.46 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Benchmark | 07 May 2025 | 40.00 (32.10%) | Beli | 31.25 |
| Wells Fargo | 07 May 2025 | 31.00 (2.38%) | Pegang | 31.25 |
| 17 Apr 2025 | 38.00 (25.50%) | Pegang | 30.28 | |
| JP Morgan | 20 Mar 2025 | 36.00 (18.89%) | Pegang | 34.88 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 06 May 2025 | Pengumuman | Omnicell Announces First Quarter 2025 Results |
| 14 Apr 2025 | Pengumuman | Omnicell to Release First Quarter 2025 Financial Results on May 6, 2025 |
| 24 Mar 2025 | Pengumuman | Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer |
| 12 Mar 2025 | Pengumuman | Omnicell Announces Chief Financial Officer Transition |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |